
The 2024 KDIGO guideline updates recommendations for evaluating, managing, and treating chronic kidney disease (CKD) in adults and children not receiving kidney replacement therapy. Key updates include increased emphasis on cystatin C for GFR assessment, expanded point-of-care testing, individualized risk-based kidney failure prediction, and recommendations for SGLT2 inhibitors and statins in CKD management. The guideline includes 28 recommendations and 141 practice points, integrating the latest evidence to improve CKD care.
Like
Save
Share